Drug · DIN 02435217
ZONOVATE
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN TRUNCATED). KIT CONTAINING A) SINGLE-USE VIAL AND B) DILUENT (4 ML PREFILLED SYRINGE)
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 24, 2026; first marketed March 23, 2018.
- Drug Identification Number (DIN)
- 02435217
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Powder For Solution; Kit
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TUROCTOCOG ALFA | 1500 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 8, 2014: NOC 16408New Drug Submission (NDS)
Other DINs named ZONOVATE
- DIN 02435187 · Dormant
- DIN 02435195 · Dormant
- DIN 02435209 · Dormant
- DIN 02435225 · Dormant
- DIN 02435233 · Dormant